Figure 2: NT5E 5’UTR variant genotype is associated with better
OS, EFS, and reduced incidence of graft rejection
Kaplan-Meier survival curves showing associations between NT5E 5’UTR
variant (rs2295890) genotype with Overall Survival (A), Event Free
Survival (B), and graft rejection (C). Patients carrying the NT5E
promoter variant genotype tended to have a better OS (p=0.25), EFS
(p=0.12), and rejection-free survival (p=0.07) compared to those with
wild-type genotype.